References
- Webb S. Motion effects in (intensity modulated) radiation therapy: a review. Phy Med Biol. 2006;51:403–425.
- Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external-beam radiotherapy. Int J Rad Oncol Biol Phy. 2002;52:1389–1399.
- Cherpak AJ, Cygler JE, Andrusyk S, et al. Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurements. Radiother Oncol. 2012;102:290–296.
- Casamassima F, Cavedon C, Francescon P, et al. Use of motion tracking in stereotactic body radiotherapy: evaluation of uncertainty in off-target dose distribution and optimization strategies. Acta Oncol. 2006;45:943–947.
- Langen K, Jones D. Organ motion and its management. Int J Rad Oncol Biol Phy. 2001;50:265–278.
- Clifford MA, Banovac F, Levy E, et al. Assessment of hepatic motion secondary to respiration for computer assisted interventions. Comp Aided Surg. 2002;7:291–299.
- Liang SX, Zhu XD, Lu HJ, et al. Hypofractionated three‐dimensional conformal radiation therapy for primary liver carcinoma. Cancer. 2005;103:2181–2188.
- Schaub SK, Hartvigson PE, Lock MI, et al. Stereotactic body radiation therapy for hepatocellular carcinoma: current trends and controversies. Technol Cancer Res Treat. 2018;17:1–19.
- Liu X, Song Y, Liang P, et al. Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients. Ott. 2017;10:5289–5295.
- Andratschke N, Parys A, Stadtfeld S, et al. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Rad Oncol. 2016;11:74–83.
- Andratschke N, Alheid H, Allgäuer M, et al. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer. 2018;18:283–293.
- Stera S, Balermpas P, Chan MKH, et al. Breathing-motion-compensated robotic guided stereotactic body radiation therapy: patterns of failure analysis. Strahlenther Onkol. 2018;194:143–155.
- Mahadevan A, Blanck O, Lanciano R, et al. Stereotactic Body Radiotherapy (SBRT) for liver metastasis–clinical outcomes from the international multi-institutional RSSearch® patient registry. Rad Oncol. 2018;13:26–36.
- Boda-Heggemann J, Jahnke A, Chan MKH, et al. Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT. Strahlenther Onkol. 2018;194:414–424.
- Aitken KL, Hawkins MA. Stereotactic body radiotherapy for liver metastases. Clin Oncol. 2015;27:307–315.
- Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys. 2006;33:3874–3900.
- Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Rad Oncol Biol Phy. 2002;53:822–834.
- Shirato H, Seppenwoolde Y, Kitamura K, et al. Intrafractional tumor motion: lung and liver. Sem Rad Oncol. 2004;14:10–18.
- Langer MP, Papiez L, Spirydovich S, et al. The need for rotational margins in intensity-modulated radiotherapy and a new method for planning target volume design. Int J Rad Oncol Biol Phy. 2005;63:1592–1603.
- Malinowski KT, McAvoy TJ, George R, et al. Mitigating errors in external respiratory surrogate-based models of tumor position. Int J Rad Oncol Biol Phy. 2012;82:709–716.
- Floriano A, García R, Moreno R, et al. Retrospective evaluation of CTV to PTV margins using CyberKnife in patients with thoracic tumors. J Appl Clin Med Phy. 2014;15:59–72.
- Antypas C, Pantelis E. Performance evaluation of a CyberKnife® G4 image-guided robotic stereotactic radiosurgery system. Phys Med Biol. 2008;53:4697–4718.
- Malinowski K, McAvoy TJ, George R, et al. Incidence of changes in respiration-induced tumor motion and its relationship with respiratory surrogates during individual treatment fractions. Int J Rad Oncol Biol Phy. 2012;82:1665–1673.
- Pepin EW, Wu H, Zhang Y, et al. Correlation and prediction uncertainties in the CyberKnife Synchrony respiratory tracking system. Med Phys. 2011;38:4036–4044.
- Hoogeman M, Prévost J-B, Nuyttens J, et al. Clinical accuracy of the respiratory tumor tracking system of the CyberKnife: assessment by analysis of log files. Int J Rad Oncol Biol Phy. 2009;74:297–303.
- Winter JD, Wong R, Swaminath A, et al. Accuracy of robotic radiosurgical liver treatment throughout the respiratory cycle. Int J Rad Oncol Biol Phy. 2015;93:916–924.
- Chan M, Grehn M, Cremers F, et al. Dosimetric implications of residual tracking errors during robotic SBRT of liver metastases. Int J Rad Oncol Biol Phy. 2017;97:839–848.
- Xu Q, Hanna G, Grimm J, et al. Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy. Int J Rad Oncol Biol Phy. 2014;90:94–101.
- Paulsson AK, Yom SS, Anwar M, et al. Respiration-induced intraorgan deformation of the liver: implications for treatment planning in patients treated with fiducial tracking. Technol Cancer Res Treat. 2017;16:776–782.
- Lu X-Q, Shanmugham LN, Mahadevan A, et al. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Rad Oncol Biol Phy. 2008;71:281–289.
- Velec M, Moseley JL, Craig T, et al. Accumulated dose in liver stereotactic body radiotherapy: positioning, breathing, and deformation effects. Int J Rad Oncol Biol Phy. 2012;83:1132–1140.
- Bertholet J, Worm E, Høyer M, et al. Cone beam CT-based set-up strategies with and without rotational correction for stereotactic body radiation therapy in the liver. Acta Oncol. 2017;56:860–866.
- Timmerman RD, Pass H, Galvin J, et al. RTOG 0618: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer 2014 [cited 2019 Jan 28]. Available from: https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?action=openFile&FileID=4650
- Kilby W, Dooley J, Kuduvalli G, et al. The CyberKnife® robotic radiosurgery system in 2010. Technol Cancer Res Treat. 2010;9:433–452.
- Ozhasoglu C, Saw CB, Chen H, et al. Synchrony–CyberKnife respiratory compensation technology. Med Dosimetry. 2008;33:117–123.
- Sothmann T, Blanck O, Poels K, et al. Real time tracking in liver SBRT: comparison of CyberKnife and Vero by planning structure-based γ-evaluation and dose-area-histograms. Phys Med Biol. 2016;61:1677–1691.
- Sayeh S, Wang J, Main WT, et al. Respiratory Motion Tracking for Robotic Radiosurgery. In: Urschel HC, Kresl JJ, Luketich JD, Papiez L, Timmerman RD, Schulz RA, editors. Treating Tumors that Move with Respiration. Berlin, Heidelberg: Springer Berlin Heidelberg; 2007. p. 15–29.
- Dieterich S, Cavedon C, Chuang CF, et al. Report of AAPM TG 135: quality assurance for robotic radiosurgery. Med Phys. 2011;38:2914–2936.
- Vandervoort E, Patrocinio H, Chow T, et al. COMP Report: CPQR technical quality control guidelines for CyberKnife® Technology. J Appl Clin Med Phys. 2018;19:29–34.
- Low DA, Dempsey JF. Evaluation of the gamma dose distribution comparison method. Med Phys. 2003;30:2455–2464.
- Wendling M, Zijp LJ, McDermott LN, et al. A fast algorithm for gamma evaluation in 3D. Med Phys. 2007;34:1647–1654.
- Neter J, Kutner MH, Nachtsheim CJ, et al. Applied linear statistical models. Chicago: Irwin; 1996.
- Fagerland MW. t-tests, non-parametric tests, and large studies—a paradox of statistical practice? BMC Med Res Methodol. 2012;12:78–84.
- Ruxton GD. The unequal variance t-test is an underused alternative to Student's t-test and the Mann–Whitney U test. Behavior Ecol. 2006;17:688–690.
- Mukaka MM. A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24:69–71.
- Murphy MJ. Fiducial-based targeting accuracy for external-beam radiotherapy. Med Phys. 2002;29:334–344.
- Jabbour SK, Hashem SA, Bosch W, et al. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Prac Rad Oncol. 2014;4:82–89.
- Kitamura K, Shirato H, Seppenwoolde Y, et al. Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. Int J Rad Oncol Biol Phy. 2003;56:221–228.
- Seppenwoolde Y, Wunderink W, Wunderink-van Veen SR, et al. Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker–tumour distance. Phys Med Biol. 2011;56:5445–5468.
- Marants R, Vandervoort E, Cygler JE. Evaluation of the 4D RADPOS dosimetry system for dose and position quality assurance of CyberKnife. Med Phys. 2018;45:4030–4044.
- Holmes OE, Gratton J, Szanto J, et al. Reducing errors in prostate tracking with an improved fiducial implantation protocol for CyberKnife based stereotactic body radiotherapy (SBRT). J Radiosurg SBRT. 2018;5:217–227.
- Gierga DP, Brewer J, Sharp GC, et al. The correlation between internal and external markers for abdominal tumors: implications for respiratory gating. Int J Rad Oncol Biol Phy. 2005;61:1551–1558.
- Liang Z, Liu H, Xue J, et al. Evaluation of the intra‐and interfractional tumor motion and variability by fiducial‐based real‐time tracking in liver stereotactic body radiation therapy. J Appl Clin Med Phys. 2018;19:94–100.